Oleg Nodelman - Feb 17, 2025 Form 3 Insider Report for Zymeworks Inc. (ZYME)

Signature
/s/ Oleg Nodelman
Stock symbol
ZYME
Transactions as of
Feb 17, 2025
Transactions value $
$0
Form type
3
Date filed
2/18/2025, 03:48 PM
Previous filing
Sep 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ZYME Common Stock 15.7M Feb 17, 2025 See Note F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ZYME Pre-Funded Warrants Feb 17, 2025 Common Stock 5.09M $0.00 See Note F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Nodelman is the manager and controlling owner of EcoR1 Capital, LLC which is the investment adviser and general partner of private funds. The funds hold these securities directy for the benefit of their investors. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1 Capital, LLC. Mr. Nodelman disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F2 The pre-funded warrants do not have an expiration date.
F3 Each pre-funded warrant is exercisable to purchase one share of Common Stock, except that the pre-funded warrants cannot be exercised if, after giving effect or immediately prior to such exercise, the reporting person, together with its affiliates and any other persons whose beneficial ownership of shares of Common Stock would be aggregated with the reporting person for purposes of Section 13(d) of the Securities Exchange Act of 1934, would beneficially own more than 19.99% of the total number of issued and outstanding shares of Common Stock or voting power of the Company following such exercise.

Remarks:

Mr. Nodelman is filing this Form 3 to report that he was appointed to the issuer's board of directors on February 17, 2025. Mr. Nodelman previously reported his beneficial ownership of the securities included in this report in the Forms 3 and Forms 4 filed by EcoR1 Capital, LLC.